Effects of diphenylhydantoin on locomotion and thigmotaxis of larval zebrafish

Neurotoxicology and Teratology

Volumn 53, Issue , 2016, Pages 41-47

  Liu, Xiuyun ^a   Lin, Jia ^a   Zhang, Yinglan ^a   Peng, Xiaolan ^a   Guo, Ning ^b   Li, Qiang ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Behavior; Diphenylhydantoin; Locomotor activity; Thigmotaxis; Zebrafish larva

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ADULT; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CLINICAL RESEARCH; COGNITION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FERTILIZATION; ILLUMINATION; LARVAL DEVELOPMENT; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; VISUAL STIMULATION; WILD TYPE; ZEBRA FISH; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; LARVA; LIGHT; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LARVA; LIGHT; MOVEMENT; PHENYTOIN; ZEBRAFISH;

EID: 84948416058     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2015.11.008     Document Type: Article

References (47)

1. Baetz M., Bowen R.C. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can. J. Psychiatr. 1998, 43(1):73-77.
2. Belzung C., Philippot P. Anxiety from a phylogenetic perspective: is there a qualitative difference between human and animal anxiety?. Neural Plast. 2007, 2007:59676.
3. Bouwknecht J.A., Paylor R. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav. Pharmacol. 2008, 19(5-6):385-402.
4. Bremner J.D., Mletzko T., et al. Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study. J. Psychopharmacol. 2005, 19(2):159-165.
5. Champagne D.L., Hoefnagels C.C., et al. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav. Brain Res. 2010, 214(2):332-342.
6. Choudhary K.M., Mishra A., et al. Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur. J. Pharmacol. 2013, 704(1-3):33-40.
7. Clift D., Richendrfer H., et al. High-throughput analysis of behavior in zebrafish larvae: effects of feeding. Zebrafish 2014, 11(5):455-461.
8. Cohn D.F., Axelrod T., et al. Effect of diphenylhydantoin on the reproductive function of the male rat. J. Neurol. Neurosurg. Psychiatry 1978, 41(9):858-860.
9. Colwill R.M., Creton R. Locomotor behaviors in zebrafish (Danio rerio) larvae. Behav. Process. 2011, 86(2):222-229.
10. de Esch C., van der Linde H., et al. Locomotor activity assay in zebrafish larvae: influence of age, strain and ethanol. Neurotoxicol. Teratol. 2012, 34(4):425-433.
11. Emran F., Rihel J., et al. A behavioral assay to measure responsiveness of zebrafish to changes in light intensities. J. Vis. Exp. 2008, 20.
12. Fetcho J.R., Liu K.S. Zebrafish as a model system for studying neuronal circuits and behavior. Ann. N. Y. Acad. Sci. 1998, 860:333-345.
13. File S.E., Lister R.G. Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions?. Neuropharmacology 1984, 23(7A):793-796.
14. Gerlai R. Zebra fish: an uncharted behavior genetic model. Behav. Genet. 2003, 33(5):461-468.
15. Hidaka N., Suemaru K., et al. Effects of repeated electroconvulsive seizures on spontaneous alternation behavior and locomotor activity in rats. Biol. Pharm. Bull. 2008, 31(10):1928-1932.
16. Irons T.D., MacPhail R.C., et al. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol. Teratol. 2010, 32(1):84-90.
17. Kallai J., Makany T., et al. Spatial orientation strategies in Morris-type virtual water task for humans. Behav. Brain Res. 2005, 159(2):187-196.
18. Kallai J., Makany T., et al. Cognitive and affective aspects of thigmotaxis strategy in humans. Behav. Neurosci. 2007, 121(1):21-30.
19. Kamei H., Kameyama T., et al. (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites. Eur. J. Pharmacol. 1996, 309(2):149-158.
20. Kim S.H., Lee I.C., et al. Dose-response effects of diphenylhydantoin on pregnant dams and embryo-fetal development in rats. Birth Defects Res. B Dev. Reprod. Toxicol. 2012, 95(5):337-345.
21. Kimmel C.B., Ballard W.W., et al. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995, 203(3):253-310.
22. Lee G.H., Sung S.Y., et al. Zebrafish larvae exposed to ginkgotoxin exhibit seizure-like behavior that is relieved by pyridoxal-5'-phosphate, GABA and anti-epileptic drugs. Dis. Model. Mech. 2012, 5(6):785-795.
23. Levin E.D., Bencan Z., et al. Anxiolytic effects of nicotine in zebrafish. Physiol. Behav. 2007, 90(1):54-58.
24. Li Q., Lin J., et al. Differential behavioral responses of zebrafish larvae to yohimbine treatment. Psychopharmacology 2014.
25. Lopez-Patino M.A., Yu L., et al. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol. Behav. 2008, 93(1-2):160-171.
26. MacPhail R.C., Brooks J., et al. Locomotion in larval zebrafish: influence of time of day, lighting and ethanol. Neurotoxicology 2009, 30(1):52-58.
27. Malizia A.L., Cunningham V.J., et al. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch. Gen. Psychiatry 1998, 55(8):715-720.
28. Minck D.R., Acuff-Smith K.D., et al. Comparison of the behavioral teratogenic potential of phenytoin, mephenytoin, ethotoin, and hydantoin in rats. Teratology 1991, 43(4):279-293.
29. Mishory A., Winokur M., et al. Prophylactic effect of phenytoin in bipolar disorder: a controlled study. Bipolar Disord. 2003, 5(6):464-467.
30. Mowery T.M., McDowell A.L., et al. Chronic developmental exposure to phenytoin has long-term behavioral consequences. Int. J. Dev. Neurosci. 2008, 26(5):401-407.
31. Munro G., Erichsen H.K., et al. Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropharmacology 2007, 53(5):609-618.
32. Padilla S., Hunter D.L., et al. Assessing locomotor activity in larval zebrafish: influence of extrinsic and intrinsic variables. Neurotoxicol. Teratol. 2011, 33(6):624-630.
33. Peitsaro N., Kaslin J., et al. Modulation of the histaminergic system and behaviour by alpha-fluoromethylhistidine in zebrafish. J. Neurochem. 2003, 86(2):432-441.
34. Pollack M.H., Matthews J., et al. Gabapentin as a potential treatment for anxiety disorders. Am. J. Psychiatry 1998, 155(7):992-993.
35. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463(1-3):3-33.
36. Reeta K.H., Mehla J., et al. Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res. 2009, 1301:52-60.
37. Richendrfer H., Pelkowski S.D., et al. Developmental sub-chronic exposure to chlorpyrifos reduces anxiety-related behavior in zebrafish larvae. Neurotoxicol. Teratol. 2012, 34(4):458-465.
38. Rodin E.A., Calhoun H.D. Metrazol tolerance in a "normal" volunteer population. A ten year follow-up report. J. Nerv. Ment. Dis. 1970, 150(6):438-443.
39. Schnorr S.J., Steenbergen P.J., et al. Measuring thigmotaxis in larval zebrafish. Behav. Brain Res. 2012, 228(2):367-374.
40. Sharma S., Coombs S., et al. The function of wall-following behaviors in the Mexican blind cavefish and a sighted relative, the Mexican tetra (Astyanax). J. Comp. Physiol. A Neuroethol. Sens. Neural Behav. Physiol. 2009, 195(3):225-240.
41. Siebel A.M., Piato A.L., et al. Antiepileptic drugs prevent changes in adenosine deamination during acute seizure episodes in adult zebrafish. Pharmacol. Biochem. Behav. 2013, 104:20-26.
42. Sousa N., Almeida O.F., et al. A hitchhiker's guide to behavioral analysis in laboratory rodents. Genes Brain Behav. 2006, 5(Suppl. 2):5-24.
43. Stahl S.M. Brainstorms: symptoms and circuits, part 2: anxiety disorders. J. Clin. Psychiatry 2003, 64(12):1408-1409.
44. Tierney K.B. Behavioural assessments of neurotoxic effects and neurodegeneration in zebrafish. Biochim. Biophys. Acta 2011, 1812(3):381-389.
45. Tonelli D.A., Pereira M., et al. The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels. Fundam. Clin. Pharmacol. 2013, 27(6):650-655.
46. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 1988, 31(4):959-962.
47. Yang T.S., Chi C.C., et al. Diphenylhydantoin teratogenicity in man. Obstet. Gynecol. 1978, 52(6):682-684.